Division of Biology of Aging, Genomics and Biomarkers Core of The Institute on Aging, Department of Aging and Geriatric Research, University of Florida, Gainesville, Florida, United States of America.
PLoS One. 2010 May 11;5(5):e10572. doi: 10.1371/journal.pone.0010572.
Mitochondrial dysfunction and oxidative stress are central mechanisms underlying the aging process and the pathogenesis of many age-related diseases. Selected antioxidants and specific combinations of nutritional compounds could target many biochemical pathways that affect both oxidative stress and mitochondrial function and, thereby, preserve or enhance physical performance.
METHODOLOGY/PRINCIPAL FINDINGS: In this study, we evaluated the potential anti-aging benefits of a Q-ter based nutritional mixture (commercially known as Eufortyn) mainly containing the following compounds: terclatrated coenzyme Q(10) (Q-ter), creatine and a standardized ginseng extract. We found that Eufortyn supplementation significantly ameliorated the age-associated decreases in grip strength and gastrocnemius subsarcolemmal mitochondria Ca(2+) retention capacity when initiated in male Fischer344 x Brown Norway rats at 21 months, but not 29 months, of age. Moreover, the increases in muscle RNA oxidation and subsarcolemmal mitochondrial protein carbonyl levels, as well as the decline of total urine antioxidant power, which develop late in life, were mitigated by Eufortyn supplementation in rats at 29 months of age.
CONCLUSIONS/SIGNIFICANCE: These data imply that Eufortyn is efficacious in reducing oxidative damage, improving the age-related mitochondrial functional decline, and preserving physical performance when initiated in animals at early midlife (21 months). The efficacy varied, however, according to the age at which the supplementation was provided, as initiation in late middle age (29 months) was incapable of restoring grip strength and mitochondrial function. Therefore, the Eufortyn supplementation may be particularly beneficial when initiated prior to major biological and functional declines that appear to occur with advancing age.
线粒体功能障碍和氧化应激是衰老过程和许多与年龄相关疾病发病机制的核心机制。一些抗氧化剂和特定的营养化合物组合可以靶向影响氧化应激和线粒体功能的许多生化途径,从而维持或增强身体机能。
方法/主要发现:在这项研究中,我们评估了基于 Q-ter 的营养混合物(商业上称为 Eufortyn)的潜在抗衰老益处,该混合物主要包含以下化合物:三氯代辅酶 Q(10)(Q-ter)、肌酸和标准化人参提取物。我们发现,Eufortyn 补充剂可显著改善雄性 Fischer344 x 布朗-挪威大鼠在 21 个月大时开始补充时的年龄相关握力下降和比目鱼肌亚肌膜线粒体 Ca(2+)保留能力下降,但在 29 个月大时则没有。此外,Eufortyn 补充剂还可以减轻肌肉 RNA 氧化和亚肌膜线粒体蛋白羰基水平的增加,以及总尿液抗氧化能力的下降,这些变化在生命后期发展。
结论/意义:这些数据表明,Eufortyn 可有效减少氧化损伤,改善与年龄相关的线粒体功能下降,并在动物中年早期(21 个月)开始时维持身体机能。然而,功效因补充开始的年龄而异,因为在中老年晚期(29 个月)开始补充无法恢复握力和线粒体功能。因此,Eufortyn 补充剂可能特别有益于在主要的生物和功能下降出现之前开始使用,这些下降似乎随着年龄的增长而发生。